QIAN Mei-jia, HU Yan, ZHU Hong, HE Qiao-jun, YANG Bo. Sirtuins in malignant progression of tumorJ. Acta Pharmaceutica Sinica, 2018,53(8): 1259-1270. doi: 10.16438/j.0513-4870.2018-0395
Citation: QIAN Mei-jia, HU Yan, ZHU Hong, HE Qiao-jun, YANG Bo. Sirtuins in malignant progression of tumorJ. Acta Pharmaceutica Sinica, 2018,53(8): 1259-1270. doi: 10.16438/j.0513-4870.2018-0395

Sirtuins in malignant progression of tumor

  • As a post-translational modification, protein acetylation plays an important role in the regulation of apoptosis, mitochondriopoiesis, lipid metabolism and cellular stress response. The imbalance of acetylation and deacetylation has been blamed for the tumorigenesis and malignant progression, which is gradually considered as a promising therapeutic target. Mammalian sirtuins, a NAD+ dependent class Ⅲ HDACs, are closely related to the development of aging, tumor, diabetes, obesity and neurodegenerative diseases. To provide a theoretical basis for the development of new anti-tumor drugs and the treatment of malignant tumors, this paper is prepared to focus on the irreplaceable role of sirtuins in tumor evolution:maintaining genomic stability, regulating energy metabolism, and facilitating tumor cells stemness. The modulator and pathways of sirtuins family and the research progress of agonists and inhibitors are also reviewed. The functions of SIRT2 in resistance, proliferation and metastasis have been highlighted.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return